Leonard Mazur
Amministratore Delegato presso CITIUS PHARMACEUTICALS, INC.
Patrimonio netto: 8 M $ in data 30/04/2024
Posizioni attive di Leonard Mazur
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| CITIUS PHARMACEUTICALS, INC. | Amministratore Delegato | 01/05/2022 | - |
| Presidente | 01/03/2016 | - | |
| Fondatore | 01/07/2013 | - | |
| Segretario Aziendale | 01/03/2016 | - | |
| Direttore/Membro del Consiglio | 12/09/2014 | 01/03/2016 | |
| Direttore operativo | 01/07/2013 | 01/03/2016 | |
| Direttore Finanziario/CFO | 12/09/2014 | 01/03/2016 | |
| Presidente | 01/07/2013 | 01/03/2016 | |
| THARIMMUNE, INC. | Direttore/Membro del Consiglio | 01/07/2021 | - |
| Independent Dir/Board Member | 01/07/2021 | - | |
| NoveCite, Inc. | Segretario Aziendale | - | - |
Citius Pharmaceuticals LLC
 Citius Pharmaceuticals LLC AluminumNon-Energy Minerals Citius Pharmaceuticals LLC markets aluminum license plate tags for automobiles. The company was founded on January 23, 2007 and is headquartered in Needham, MA. | Amministratore Delegato | - | - |
| Manor College | Direttore/Membro del Consiglio | - | - |
Akrimax Pharmaceuticals LLC
 Akrimax Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Akrimax Pharmaceuticals LLC manufactures medicines for metabolic syndrome. The company's products include Inderal and Lo/Ovral. The company was founded in 2007 by Joseph J. Krivulka and Leonard L. Mazur and is headquartered in Cranford, NJ | Direttore/Membro del Consiglio | 01/09/2008 | - |
| Fondatore | 01/09/2008 | - | |
Citius Oncology, Inc.
 Citius Oncology, Inc. Pharmaceuticals: MajorHealth Technology Part of Citius Pharmaceuticals, Inc., Citius Oncology, Inc. is a late-stage pharmaceutical company focused on developing and commercializing targeted oncology therapies. The company is based in Cranford, NJ. Citius Oncology's strategy centers on advancing innovative therapies with reduced development and clinical risks, leveraging competitive advantages supported by intellectual property and regulatory exclusivity protection. The company's lead product candidate is lymphir, an engineered il-2 diphtheria toxin fusion protein, for the treatment of patients with persistent or recurrent ctcl, a rare form of non-Hodgkin lymphoma. The company was founded in 2021, and the CEO is Leonard L. Mazur. | Amministratore Delegato | - | - |
| Presidente | - | - |
Storia della carriera di Leonard Mazur
Precedenti posizioni note di Leonard Mazur
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Triax Pharmaceuticals LLC
 Triax Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Triax Pharmaceuticals LLC manufactures, distributes, and markets dermatological products. The company was founded by Leonard L. Mazur and Joseph J. Krivulka in November 2004 and is headquartered in Cranford, NJ. | Direttore operativo | 01/01/2005 | 31/05/2012 |
| Fondatore | 01/11/2004 | 31/05/2012 | |
| FC GLOBAL REALTY INC | Direttore/Membro del Consiglio | 15/05/2009 | 13/12/2011 |
| Independent Dir/Board Member | 22/08/2011 | 13/12/2011 | |
| ░░░░░ ░░░░░░░░ ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░ ░░░░░░░░░ | - | - |
| ░░░░░ ░░░░░░░░░░░░░░ ░░░ | ░░░░░ ░ ░░░░░░░░░ | - | - |
| ░░░░░░░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░░░░ ░░░░ ░░░░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░░░░░░░░ ░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - | |
| ░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░░░ ░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░░░ ░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░ ░ ░░░░░░░░░ | - | - |
Formazione di Leonard Mazur
| Temple University (Pennsylvania) | Masters Business Admin |
Statistiche
Distribuzione geografica
| Stati Uniti | 20 |
Posizioni
| Director/Board Member | 9 |
| Founder | 4 |
| Chief Executive Officer | 4 |
Settori
| Health Technology | 11 |
| Consumer Services | 3 |
| Finance | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| CITIUS PHARMACEUTICALS, INC. | Health Technology |
| THARIMMUNE, INC. | Health Technology |
| Aziende private | 15 |
|---|---|
Triax Pharmaceuticals LLC
Triax Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Triax Pharmaceuticals LLC manufactures, distributes, and markets dermatological products. The company was founded by Leonard L. Mazur and Joseph J. Krivulka in November 2004 and is headquartered in Cranford, NJ. | Health Technology |
Bausch Health Americas, Inc.
 Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Bausch Health Americas, Inc. manufactures and distributes pharmaceutical products. The company was founded on November 29, 2011 and is headquartered in Bridgewater, NJ. | Health Technology |
Akrimax Pharmaceuticals LLC
Akrimax Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Akrimax Pharmaceuticals LLC manufactures medicines for metabolic syndrome. The company's products include Inderal and Lo/Ovral. The company was founded in 2007 by Joseph J. Krivulka and Leonard L. Mazur and is headquartered in Cranford, NJ | Health Technology |
FC Global Realty, Inc.
 FC Global Realty, Inc. Real Estate DevelopmentFinance FC Global Realty, Inc. engages in the acquisition, development, and management of commercial and residential real estate properties. It focuses on investments in high yield income producing assets and other opportunistic commercial properties via direct property ownership and asset management. The company was founded in 1980 and is headquartered in Willow Grove, PA. | Finance |
Medicis Pharmaceutical Corp.
 Medicis Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Medicis Pharmaceutical Corp. develops and markets pharmaceutical products for dermatological usages. It offers a broad range of products addressing various conditions or aesthetic improvements, including facial wrinkles, glabellar lines, acne, fungal infections, rosacea, hyperpigmentation, photoaging, psoriasis, seborrheic dermatitis and cosmesis. The company was founded on July 28, 1988 and is headquartered in Phoenix, AZ. | Health Technology |
| Genesis Pharmaceuticals | Commercial Services |
Media Exchange Group, Inc.
 Media Exchange Group, Inc. Information Technology ServicesTechnology Services Media Exchange Group, Inc. is a digital media, technology, entertainment, wireless gamming and mobile publishing company. The company provides content in the form of mobile applications, digital media, web and broadcast products via its unique mix of acquisitions, on deck partnerships, license agreements, and joint venture revenue share arrangements. The company's current plan of operations consists of capitalizing on its digital sport cards delivery to youth and acquiring an operating business. Media Exchange Group has signed merger agreement with Intellicell Biosciences. The company was founded on March 8, 1999 and is headquartered in Los Gatos, CA | Technology Services |
Intellicell Biosciences, Inc.
 Intellicell Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Intellicell Biosciences, Inc. develops stem cell derived pharmaceuticals. The company identified the technologies and laboratory process to target a portfolio of products and services in personalized medicine for the regenerative, preventative, and curative elements of age related disease states. The company was founded on June 3, 2011 and is headquartered in New York, NY. | Health Technology |
SENTÉ, Inc. (California)
 SENTÉ, Inc. (California) Specialty StoresRetail Trade SENTÉ, Inc. provides skin care products. The firm's products include Daily Repair Complex, Neck Firming and Redness Control Complex creams. It offers dermal repair cream for people of various age groups and skin types for enhancing the skin tone, texture, elasticity, and overall appearance. The company serves customers through dermatologists and physicians in the United States. Sente was founded by Kleanthis G. Xanthopoulos and Marios Fotiadis in 2007 and is headquartered in Carlsbad, CA. | Retail Trade |
Leonard-Meron Biosciences, Inc.
 Leonard-Meron Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Leonard-Meron Biosciences, Inc. develops and commercializes critical care products. It offers Mino-Lok, an antibiotic lock solution used to treat patients with catheter-related bloodstream infections. The company was founded by Myron Z. Holubiak in October 2013 and is headquartered in Cranford, NJ. | Health Technology |
Citius Pharmaceuticals LLC
Citius Pharmaceuticals LLC AluminumNon-Energy Minerals Citius Pharmaceuticals LLC markets aluminum license plate tags for automobiles. The company was founded on January 23, 2007 and is headquartered in Needham, MA. | Non-Energy Minerals |
| Knoll Pharmaceutical Co. | |
| Cooper Laboratories, Inc. | Health Technology |
| NoveCite, Inc. | |
Citius Oncology, Inc.
Citius Oncology, Inc. Pharmaceuticals: MajorHealth Technology Part of Citius Pharmaceuticals, Inc., Citius Oncology, Inc. is a late-stage pharmaceutical company focused on developing and commercializing targeted oncology therapies. The company is based in Cranford, NJ. Citius Oncology's strategy centers on advancing innovative therapies with reduced development and clinical risks, leveraging competitive advantages supported by intellectual property and regulatory exclusivity protection. The company's lead product candidate is lymphir, an engineered il-2 diphtheria toxin fusion protein, for the treatment of patients with persistent or recurrent ctcl, a rare form of non-Hodgkin lymphoma. The company was founded in 2021, and the CEO is Leonard L. Mazur. | Health Technology |
- Borsa valori
- Insiders
- Leonard Mazur
- Esperienza
